Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-05-19 Purchase | 2026-05-21 8:59 pm | Keenova Therapeutics plc | Silver Point Capital L.P. MULE EDWARD A O'Shea Robert J 10% Owner | 397,500 | $90.5 | $35,973,750 | 6,035,214 (Direct) | View | |
| 2026-04-15 Purchase | 2026-04-17 5:23 pm | Keenova Therapeutics plc | Silver Point Capital L.P. MULE EDWARD A O'Shea Robert J 10% Owner | 685,000 | $89.7 | $61,442,500 | 5,637,714 (Direct) | View | |
| 2026-01-07 Purchase | 2026-01-09 5:26 pm | Keenova Therapeutics plc | Silver Point Capital L.P. MULE EDWARD A O'Shea Robert J 10% Owner | 250,000 | $92.25 | $23,062,500 | 4,952,714 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-02 Tax Withholding | 2026-06-04 4:14 pm | N/A N/A | Keenova Therapeutics plc | Langlois Sophia J. Director | 1,289 | $0 | 12,844 (Direct) | View | |
| 2026-06-02 Exercise | 2026-06-04 4:14 pm | N/A N/A | Keenova Therapeutics plc | Langlois Sophia J. Director | 2,685 | $0 | 12,844 (Direct) | View | |
| 2026-06-02 Tax Withholding | 2026-06-04 4:13 pm | N/A N/A | Keenova Therapeutics plc | Hirsch Scott Director | 619 | $0 | 13,174 (Direct) | View | |
| 2026-06-02 Exercise | 2026-06-04 4:13 pm | N/A N/A | Keenova Therapeutics plc | Hirsch Scott Director | 2,685 | $0 | 13,174 (Direct) | View | |
| 2026-06-02 Tax Withholding | 2026-06-04 4:12 pm | N/A N/A | Keenova Therapeutics plc | Efron Paul Director | 825 | $0 | 22,768 (Direct) | View | |
| 2026-06-02 Exercise | 2026-06-04 4:12 pm | N/A N/A | Keenova Therapeutics plc | Efron Paul Director | 3,580 | $0 | 22,768 (Direct) | View | |
| 2026-06-02 Exercise | 2026-06-04 4:12 pm | N/A N/A | Keenova Therapeutics plc | Dorton Katina Director | 4,882 | $0 | 34,387 (Direct) | View | |
| 2026-06-02 Exercise | 2026-06-04 4:11 pm | N/A N/A | Keenova Therapeutics plc | Donato Leslie E Director | 4,882 | $0 | 8,866 (Direct) | View | |
| 2026-06-02 Tax Withholding | 2026-06-04 4:11 pm | N/A N/A | Keenova Therapeutics plc | Bisaro Paul Director | 619 | $0 | 93,615 (Direct) | View | |
| 2026-06-02 Exercise | 2026-06-04 4:11 pm | N/A N/A | Keenova Therapeutics plc | Bisaro Paul Director | 2,685 | $0 | 93,615 (Direct) | View | |
| 2026-06-02 Exercise | 2026-06-04 4:10 pm | N/A N/A | Keenova Therapeutics plc | Zinman Jon Director | 4,882 | $0 | 47,585 (Direct) | View | |
| 2026-06-02 Tax Withholding | 2026-06-04 4:10 pm | N/A N/A | Keenova Therapeutics plc | Yoskowitz Marc J Director | 825 | $0 | 17,744 (Direct) | View | |
| 2026-06-02 Exercise | 2026-06-04 4:10 pm | N/A N/A | Keenova Therapeutics plc | Yoskowitz Marc J Director | 3,579 | $0 | 17,744 (Direct) | View | |
| 2026-04-23 Exercise | 2026-04-24 8:02 pm | N/A N/A | Keenova Therapeutics plc | Basso Tracy EVP & CHRO | 1,523 | $0 | 49,022 (Direct) | View | |
| 2026-04-23 Exercise | 2026-04-24 8:00 pm | N/A N/A | Keenova Therapeutics plc | Stouch Cheryl Ann EVP & Chief Info Officer | 1,137 | $0 | 26,800 (Direct) | View | |
| 2026-04-23 Exercise | 2026-04-24 8:00 pm | N/A N/A | Keenova Therapeutics plc | Williamson Susan Ann EVP & Chief Compliance Officer | 1,305 | $0 | 28,409 (Direct) | View | |
| 2026-02-25 Option Award | 2026-02-26 9:15 pm | N/A N/A | Keenova Therapeutics plc | Nielsen Henriette EVP & Chief Transformation OFC | 51,794 | $0 | 97,825 (Direct) | View | |
| 2026-02-25 Option Award | 2026-02-26 9:13 pm | N/A N/A | Keenova Therapeutics plc | Honczarenko Marek EVP, Chief Scientific Officer | 58,434 | $0 | 58,434 (Direct) | View | |
| 2026-02-25 Option Award | 2026-02-26 9:11 pm | N/A N/A | Keenova Therapeutics plc | French Lisa EVP & Chief Commercial Officer | 51,794 | $0 | 97,825 (Direct) | View | |
| 2026-02-25 Option Award | 2026-02-26 9:09 pm | N/A N/A | Keenova Therapeutics plc | Basso Tracy EVP & CHRO | 34,528 | $0 | 48,240 (Direct) | View | |
| 2026-02-25 Option Award | 2026-02-26 9:07 pm | N/A N/A | Keenova Therapeutics plc | Williamson Susan Ann EVP & Chief Compliance Officer | 15,936 | $0 | 27,683 (Direct) | View | |
| 2026-02-25 Option Award | 2026-02-26 9:05 pm | N/A N/A | Keenova Therapeutics plc | Tyndall Mark Anthony EVP & CLO and Corp Sec | 51,794 | $0 | 97,825 (Direct) | View | |
| 2026-02-25 Option Award | 2026-02-26 9:04 pm | N/A N/A | Keenova Therapeutics plc | Stouch Cheryl Ann EVP & Chief Info Officer | 15,936 | $0 | 26,169 (Direct) | View | |
| 2026-02-25 Option Award | 2026-02-26 9:02 pm | N/A N/A | Keenova Therapeutics plc | Stamoulis Christiana President and CFO | 101,262 | $0 | 174,181 (Direct) | View | |
| 2026-02-25 Option Award | 2026-02-26 9:01 pm | N/A N/A | Keenova Therapeutics plc | ONeill Hugh Paul EVP, Chief Operations Officer | 34,528 | $0 | 48,913 (Direct) | View | |
| 2026-02-25 Option Award | 2026-02-26 9:00 pm | N/A N/A | Keenova Therapeutics plc | Olafsson Sigurdur O President and CEO | 198,539 | $0 | 506,815 (Direct) | View | |
| 2026-02-23 Option Award | 2026-02-25 8:59 pm | N/A N/A | Keenova Therapeutics plc | Zinman Jon Director | 3,984 | $0 | 39,554 (Direct) | View | |
| 2026-02-23 Option Award | 2026-02-25 8:57 pm | N/A N/A | Keenova Therapeutics plc | Yoskowitz Marc J Director | 5,312 | $0 | 11,821 (Direct) | View | |
| 2026-02-23 Option Award | 2026-02-25 8:55 pm | N/A N/A | Keenova Therapeutics plc | Langlois Sophia D. Director | 3,984 | $0 | 8,866 (Direct) | View | |
| 2026-02-23 Option Award | 2026-02-25 8:53 pm | N/A N/A | Keenova Therapeutics plc | Hirsch Scott Director | 3,984 | $0 | 8,866 (Direct) | View | |
| 2026-02-23 Option Award | 2026-02-25 8:50 pm | N/A N/A | Keenova Therapeutics plc | Efron Paul Director | 3,984 | $0 | 10,494 (Direct) | View | |
| 2026-02-23 Option Award | 2026-02-25 8:48 pm | N/A N/A | Keenova Therapeutics plc | Dorton Katina Director | 3,984 | $0 | 31,882 (Direct) | View | |
| 2026-02-23 Option Award | 2026-02-25 8:47 pm | N/A N/A | Keenova Therapeutics plc | Donato Leslie E Director | 3,984 | $0 | 8,866 (Direct) | View | |
| 2026-02-23 Option Award | 2026-02-25 8:45 pm | N/A N/A | Keenova Therapeutics plc | Bisaro Paul Director | 3,984 | $0 | 47,225 (Direct) | View | |
| 2025-07-31 Other | 2026-02-12 4:30 pm | N/A N/A | Keenova Therapeutics plc | GOLDENTREE ASSET MANAGEMENT LP GoldenTree Asset Management LLC Tananbaum Steven A. 10% Owner | 33,651 | $0 | 8,013,478 (Indirect) | View | |
| 2026-01-01 Exercise | 2026-01-05 6:05 pm | N/A N/A | Keenova Therapeutics plc | Zinman Jon Director | 4,384 | $0 | 43,601 (Direct) | View | |
| 2026-01-01 Tax Withholding | 2026-01-05 6:04 pm | N/A N/A | Keenova Therapeutics plc | Tyndall Mark Anthony EVP & CLO and Corp Sec | 2,107 | $0 | 54,198 (Direct) | View | |
| 2026-01-01 Exercise | 2026-01-05 6:04 pm | N/A N/A | Keenova Therapeutics plc | Tyndall Mark Anthony EVP & CLO and Corp Sec | 6,576 | $0 | 54,198 (Direct) | View | |
| 2026-01-01 Tax Withholding | 2026-01-05 6:03 pm | N/A N/A | Keenova Therapeutics plc | ONeill Hugh Paul EVP, Qual & Ops, Spec Brands | 1,073 | $0 | 16,187 (Direct) | View | |
| 2026-01-01 Exercise | 2026-01-05 6:03 pm | N/A N/A | Keenova Therapeutics plc | ONeill Hugh Paul EVP, Qual & Ops, Spec Brands | 2,055 | $0 | 16,187 (Direct) | View | |
| 2026-01-01 Tax Withholding | 2026-01-05 6:03 pm | N/A N/A | Keenova Therapeutics plc | Olafsson Sigurdur O President and CEO | 16,939 | $0 | 339,994 (Direct) | View | |
| 2026-01-01 Exercise | 2026-01-05 6:03 pm | N/A N/A | Keenova Therapeutics plc | Olafsson Sigurdur O President and CEO | 32,878 | $0 | 339,994 (Direct) | View | |
| 2026-01-01 Tax Withholding | 2026-01-05 6:02 pm | N/A N/A | Keenova Therapeutics plc | Nielsen Henriette EVP & Chief Transformation OFC | 2,398 | $0 | 53,569 (Direct) | View | |
| 2026-01-01 Exercise | 2026-01-05 6:02 pm | N/A N/A | Keenova Therapeutics plc | Nielsen Henriette EVP & Chief Transformation OFC | 6,576 | $0 | 53,569 (Direct) | View | |
| 2026-01-01 Tax Withholding | 2026-01-05 6:01 pm | N/A N/A | Keenova Therapeutics plc | French Lisa EVP & Chief Commercial Officer | 1,986 | $0 | 54,421 (Direct) | View | |
| 2026-01-01 Exercise | 2026-01-05 6:01 pm | N/A N/A | Keenova Therapeutics plc | French Lisa EVP & Chief Commercial Officer | 6,576 | $0 | 54,421 (Direct) | View | |
| 2026-01-01 Tax Withholding | 2026-01-05 6:00 pm | N/A N/A | Keenova Therapeutics plc | Dorton Katina Director | 513 | $0 | 60,109 (Direct) | View | |
| 2026-01-01 Exercise | 2026-01-05 6:00 pm | N/A N/A | Keenova Therapeutics plc | Dorton Katina Director | 1,808 | $0 | 60,109 (Direct) | View |